Antidepressant Serotonin Reuptake Inhib. (SSRIs,SNRIs,SDRIs)

(SSRIs,SNRIs,SDRIs)" is an administrative formulary grouping rather than a single recognized pharmacologic drug class

(SSRIs,SNRIs,SDRIs)" is an administrative formulary grouping rather than a single recognized pharmacologic drug class

It aggregates monoamine reuptake inhibitors that enhance serotonergic, and variously noradrenergic or dopaminergic, neurotransmission by blocking the reuptake of these monoamines at presynaptic nerve terminals These medications—most prominently selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), alongside less clinically prevalent serotonin-dopamine reuptake inhibitors (SDRIs)—serve as first-line pharmacotherapies across mental health In clin...

It aggregates monoamine reuptake inhibitors that enhance serotonergic, and variously noradrenergic or dopaminergic, neurotransmission by blocking the reuptake of these monoamines at presynaptic nerve terminals

It aggregates monoamine reuptake inhibitors that enhance serotonergic, and variously noradrenergic or dopaminergic, neurotransmission by blocking the reuptake of these monoamines at presynaptic nerve terminals

These medications—most prominently selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), alongside less clinically prevalent serotonin-dopamine reuptake inhibitors (SDRIs)—serve as first-line pharmacotherapies across mental health

These medications—most prominently selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), alongside less clinically prevalent serotonin-dopamine reuptake inhibitors (SDRIs)—serve as first-line pharmacotherapies across mental health

In clinical practice, they are predominantly utilized to treat major depressive disorder, generalized anxiety disorder, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder